SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-074790
Filing Date
2022-06-27
Accepted
2022-06-27 16:38:39
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2219332-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2219332-2_3seq1.xml 3 3626
  Complete submission text file 0001104659-22-074790.txt   5812
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38841 | Film No.: 221045120

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38841 | Film No.: 221045119
SIC: 2834 Pharmaceutical Preparations

Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Issuer) CIK: 0001357874 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)